Latest stories on GENB
Generate Biomedicines to Participate in November Investor Conferences
GlobeNewswire52 · neutralproduct/pr
Generate Biomedicines management to meet with Cantor
The Fly56 · neutralgeneral
Generate Biomedicines: Zealand Deal For Obesity Programs May Not Be Quite What It Seems
Seeking Alpha48 · neutralm&a
Generate, Zealand in collaboration to develop drugs for obesity, metabolic diseases
Seeking Alpha63 · neutralproduct/pr
Generate Biomedicines, Zealand Pharma enter protein therapeutics pact
The Fly63 · neutralproduct/pr
Generate Biomedicines: The Dosing Interval Is The Moat, Not The Algorithm
Seeking Alpha63 · neutralproduct/pr
GENB Volatility Term Structure for Generate Biomedicines Stock
Barchart50 · neutralgeneral
GENB Gamma Exposure (GEX) for Generate Biomedicines Stock
Barchart50 · neutralgeneral
GENB Long Call Condor for Generate Biomedicines Stock
Barchart50 · neutralgeneral
Generate Biomedicines, Roswell Park dose first patient in GB-5267 trial
The Fly56 · neutralproduct/pr
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
Business Insider67 · bullishproduct/pr
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
GlobeNewswire67 · bullishproduct/pr
Generate Biomedicines, Inc. (GENB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
Generate Biomedicines Inc. to Participate in September Investor Conferences
GlobeNewswire56 · neutralgeneral
Generate Biomedicines stock price target raised to $30 by H.C. Wainwright on asthma data
Investing.com Analyst Ratings63 · neutralanalyst
Generate Biomedicines price target raised to $30 from $25 at H.C. Wainwright
The Fly61 · neutralanalyst
EXCLUSIVE: Nvidia GPUs Are Essential—But They Won't Decide Who Wins AI Drug Discovery, Generate CTO Says
Yahoo Top54 · neutralproduct/pr
Generate Biomedicines falls -16.7%
The Fly34 · bearishgeneral
Generate Biomedicines falls -11.0%
The Fly39 · neutralgeneral
Generate Biomedicines, Inc. (GENB) files 8-K
SEC 8-K50 · neutralgeneral
Generate Biomedicines surges again, rises 12% to new high
Seeking Alpha73 · bullishgeneral